The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study (2021)
- Authors:
- Autor USP: NICOLAU, JOSÉ CARLOS - FM
- Unidade: FM
- DOI: 10.1093/eurheartj/ehab234
- Subjects: FERRO; INSUFICIÊNCIA CARDÍACA; FERRO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: European heart journal
- ISSN: 0195-668X
- Volume/Número/Paginação/Ano: v. 42, n. 31, p. 3011-+, 2021
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
JANKOWSKA, Ewa A et al. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, v. 42, n. 31, p. 3011-+, 2021Tradução . . Disponível em: https://doi.org/10.1093/eurheartj/ehab234. Acesso em: 14 fev. 2026. -
APA
Jankowska, E. A., Kirwan, B. -A., Kosiborod, M., Butler, J., Anker, S. D., Mcdonagh, T., et al. (2021). The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study. European heart journal, 42( 31), 3011-+. doi:10.1093/eurheartj/ehab234 -
NLM
Jankowska EA, Kirwan B-A, Kosiborod M, Butler J, Anker SD, Mcdonagh T, Dorobantu M, Drozdz J, Filippatos G, Nicolau JC. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [Internet]. European heart journal. 2021 ; 42( 31): 3011-+.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1093/eurheartj/ehab234 -
Vancouver
Jankowska EA, Kirwan B-A, Kosiborod M, Butler J, Anker SD, Mcdonagh T, Dorobantu M, Drozdz J, Filippatos G, Nicolau JC. The effect of intravenous ferric carboxymaltose on heatlh-related quality of life in iron-deficient patients with acute heart failure: the results of the AFFIRM-AHF study [Internet]. European heart journal. 2021 ; 42( 31): 3011-+.[citado 2026 fev. 14 ] Available from: https://doi.org/10.1093/eurheartj/ehab234 - Sex difference in patients with ischemic heart failure undergoing surgical revascularization results from the STICH trial (Surgical Treatment for Ischemic Heart Failure)
- Activated Clotting Time to Guide Heparin Dosing in Non-ST-Segment-Elevation Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention and Treated With IIb/IIIa Inhibitors Impact on Ischemic and Bleeding Outcomes: Insights From the TAO Trial
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Coronary Stent Registry
- Anticoagulation With Otamixaban and Ischemic Events in Non–ST-Segment Elevation Acute Coronary Syndromes: The TAO Randomized Clinical Trial
- Aneurisma Verdadeiro Gigante e Calcificado do Ventrículo Esquerdo: como Proceder?
- Effect of dapagliflozin on outpatient worsening of patients with heart failure and reduced ejection fraction a prespecified analysis of DAPA-HF
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)
- Comparison between two different local hemostatic methods for dental extractions in patients on dual antiplatelet therapy: a within-person, single-blind, randomized study
- Randomized, placebo-controlled phase 2b study to evaluate the safety and efficacy of recombinant human lecithin cholesterol acyltransferase in acute ST-segment-elevation myocardial infarction: results of REAL-TIMI 63B
- Predictors of subclinical carotid atherosclerosis in middle-aged women
Informações sobre o DOI: 10.1093/eurheartj/ehab234 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
